McKesson Corporation (NYSE:MCK) reached a new 52-week high on Thursday, trading at an impressive $964.94 after a robust earnings report. The stock, which closed at $822.00 the previous day, settled at $958.92 with a trading volume of 586,810 shares. The surge in share price followed the company announcing a quarterly earnings per share (EPS) of $9.34, exceeding analysts’ expectations of $9.19 by $0.15.
In the latest quarter, McKesson reported revenue of $106.16 billion, surpassing the consensus estimate of $105.98 billion. This figure marks an 11.4% increase compared to the same quarter last year when the company posted an EPS of $8.03. Looking ahead, McKesson has set its fiscal year 2026 guidance between $38.800 and $39.200 EPS.
Dividend Announcement and Analyst Ratings
In addition to its strong earnings report, McKesson announced a quarterly dividend of $0.82, scheduled for payment on April 1, 2026. Shareholders of record on March 2 will receive this dividend, representing an annualized payout of $3.28 and a yield of 0.3%. The company’s current dividend payout ratio stands at 10.21%.
Wall Street analysts have responded positively to McKesson’s performance. Evercore ISI reiterated an “outperform” rating with a price target of $1,000.00 per share. Meanwhile, TD Cowen maintained a “buy” rating, and Jefferies Financial Group raised its price objective from $820.00 to $900.00. Conversely, Zacks Research downgraded McKesson from a “strong-buy” to a “hold” rating. Currently, two analysts rate the stock as a Strong Buy, eleven as a Buy, and four as a Hold, leading to a consensus rating of “Moderate Buy” with an average target price of $908.36, according to MarketBeat.com.
Insider Transactions and Institutional Holdings
Recent insider activity has also drawn attention. Chief Accounting Officer Napoleon B. Rutledge, Jr. sold 329 shares at an average price of $861.63, totaling approximately $283,476.27. This transaction reduced his ownership by 50.08%. Additionally, Executive Vice President Thomas L. Rodgers sold 276 shares at an average price of $816.18, resulting in a decrease of 10.85% in his holdings.
Institutional investors continue to show interest in McKesson. GGM Financials LLC acquired a new stake worth $25,000 in the third quarter. Other notable movements include Solstein Capital LLC, which increased its holdings by 171.4%, and several hedge funds making new investments ranging from $25,000 to $31,000. Overall, institutional investors own approximately 85.07% of McKesson’s stock.
The company’s stock performance reflects its solid fundamentals, with a market capitalization of $118.14 billion, a price-to-earnings (P/E) ratio of 29.94, and a beta of 0.40. McKesson’s 50-day moving average stands at $825.54, while its 200-day moving average is $776.66.
Founded in 1833 and headquartered in Irving, Texas, McKesson Corporation is a global leader in healthcare services and distribution. The company provides pharmaceuticals, medical-surgical products, and healthcare technology solutions, connecting manufacturers, pharmacies, hospitals, and health systems to enhance the management of medicines and clinical supplies. Its core activities include pharmaceutical wholesale distribution, logistics, and specialty pharmacy services.
